Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
Cerebral ischemia is the second leading cause of death in the world and multimodal stroke therapy is needed. The ischemic stroke generally reduces the gene expression due to suppression of acetylation of histones H3 and H4. Histone deacetylases inhibitors have been shown to be effective in protectin...
Những tác giả chính: | Svetlana Demyanenko, Valentina Dzreyan, Svetlana Sharifulina |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
MDPI AG
2021-10-01
|
Loạt: | Biomedicines |
Những chủ đề: | |
Truy cập trực tuyến: | https://www.mdpi.com/2227-9059/9/10/1445 |
Những quyển sách tương tự
-
Histone Deacetylases and their Inhibitors in Cancer Epigenetics
Bằng: Kelly N. Hassell
Được phát hành: (2019-11-01) -
Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
Bằng: Masumeh Sanaei, et al.
Được phát hành: (2019-01-01) -
Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
Bằng: Fengyi Guo, et al.
Được phát hành: (2022-11-01) -
Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke
Bằng: Ying Tang, et al.
Được phát hành: (2017-10-01) -
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
Bằng: Yan Li, et al.
Được phát hành: (2022-05-01)